Radiotherapy with high-energy charged particles has become an attractive therapeutic
option for patients with several tumour types because this approach better spares healthy …

Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

Purpose: This guideline is structured to provide a clinical framework stratified by cancer
severity to facilitate care decisions and guide the specifics of implementing the selected …

Though single tumor immunotherapy and radiotherapy have significantly improved the
survival rate of tumor patients, there are certain limitations in overcoming tumor metastasis …

Proton beam therapy (PBT) has been increasingly used in a variety of cancers due to its
excellent physical properties and superior dosimetric parameters. PBT may improve patient …

Neuroendocrine differentiation (NED) in prostate cancer is a well-recognized phenotypic
change by which prostate cancer cells transdifferentiate into neuroendocrine-like (NE-like) …

More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …

Purpose Following a prostate cancer diagnosis, patients are faced with a multitude of care
options, the advisability of which is influenced by patient factors and by cancer severity or …

Radiation therapy (RT) is a curative treatment modality for localized prostate cancer. Over
the past two decades, advances in technology and imaging have considerably changed RT …

Purpose: The effect of time between radical prostatectomy and radiation therapy on
postoperative functional outcomes is still unclear in patients with surgically managed …